[{
    "name": "OLAPARIB",
    "smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
    "originator": "AstraZeneca",
    "originator_uri": "http://www.drugdevelopment-technology.com/projects/lynparza-olaparib-cancer/",
    "originator_comment": " ",
    "compound_description": "Olaparib is an oral inhibitor of poly (ADP-ribose) polymerase enzymes, including PARP1, PARP2, and PARP3 which are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA\nrepair. Olaparib has shown activity in ovarian and breast tumors with known BRCA mutations and was the first FDA approved drug in this class. Lynparza (olaparib) is indicated for treatment of gBRCA-mutated advanced ovarian cancer. Its use together with other chemotherapy medicines can lead to increased effects on the blood resulting in reduction in the numbers of white blood cells and platelets, and anaemia.",
    "description_uri": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
    "description_comment": "Description was created based on several sources, including:\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880823/",
    "in_vivo_use_guide": "400 mg (eight 50 mg capsules) taken twice daily, for a total daily dose of 800 mg. Continue treatment until disease progression or unacceptable toxicity.",
    "in_vivo_use_route": "Oral",
    "in_vivo_uri": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
    "in_vitro_use_guide": "30-100 nM in SW620 cells",
    "in_vitro_uri": "http://www.ncbi.nlm.nih.gov/pubmed/?term=18800822",
    "structure_alert": "False",
    "cns": "Unknown",
    "cns_uri": "Unknown",
    "curated_by": "oleg.stroganov@gmail.com",
    "modified_datetime": 1631723821889.0,
    "qcd": false,
    "unii": "WOH1JD9AR8",
    "cas": "763113-22-0",
    "iupac": "4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one",
    "cid": "23725625",
    "wikiurl": "https://en.wikipedia.org/wiki/olaparib",
    "chembl_id": "CHEMBL521686",
    "drugbank_id": "DB09074",
    "chemspider_id": "23343272",
    "kegg_id": "D09730",
    "bindingdb_id": "27566",
    "synonyms": [
        "1(2H)-PHTHALAZINONE, 4-((3-((4-(CYCLOPROPYLCARBONYL)-1-PIPERAZINYL)CARBONYL)-4-FLUOROPHENYL)METHYL)-",
        "4-((3-((4-(CYCLOPROPYLCARBONYL)PIPERAZIN-1-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)PHTHALAZIN-1(2H)-ONE",
        "AZD-2281",
        "AZD2281",
        "KU-0059436",
        "KU-59436",
        "LYNPARZA",
        "OLAPARIB",
        "OLAPARIBUM",
        "PIPERAZINE, 1-(CYCLOPROPYLCARBONYL)-4-(5-((3,4-DIHYDRO-4-OXO-1-PHTHALAZINYL)METHYL)-2-FLUOROBENZOYL)-",
        "\u041e\u041b\u0410\u041f\u0410\u0420\u0418\u0411",
        "\u0623\u0648\u0644\u0627\u0628\u0627\u0631\u064a\u0628",
        "\u5965\u62c9\u5e15\u5229",
        "DB09074"
    ],
    "pmids": [
        "26544897",
        "26510020",
        "252160170",
        "24833294",
        "23118055",
        "22683710",
        "22194930",
        "21633166",
        "21417348",
        "21285347",
        "21188115",
        "21172086",
        "21152454",
        "21080930",
        "21069103",
        "21050424",
        "21050423",
        "21050422",
        "20979652",
        "20978505",
        "20976249",
        "20956982",
        "20948822",
        "20948704",
        "20922827",
        "20920367",
        "20871615",
        "20739657",
        "20725763",
        "20697530",
        "20647699",
        "20609468",
        "20609467",
        "20530711",
        "20506057",
        "20485165",
        "20459590",
        "20406929",
        "20404603",
        "20385032",
        "20383346",
        "20376879",
        "20149218",
        "20145144",
        "20130818",
        "20124459",
        "20111741",
        "20069122",
        "20049732",
        "20049345",
        "20030882",
        "20030873",
        "20017885",
        "20008842",
        "19904273",
        "19863774",
        "19825178",
        "19671736",
        "19647219",
        "19632796",
        "19589159",
        "19553641",
        "18971340",
        "18800822",
        "12857389"
    ],
    "patent": [
        "20080200469",
        "20080146575",
        "08247416",
        "08183369",
        "07692006"
    ],
    "conditions": [
        {
            "compound_id": 8.0,
            "name": "Ovarian cancer",
            "condition_uri": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
            "condition_comment": " ",
            "product_name": "LYNPARZA",
            "product_date": 1418947200000,
            "condition_highest_phase": "Approved",
            "highest_phase_uri": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
            "fda_use": "Monotherapy in patients with deleterious or suspected deleterious germline BRCA mutated advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.",
            "offlabel_use": "Metastatic castrate resistant prostate cancer|Recurrent breast cancer with BRCA1/2 mutation|Recurrent or metastatic gastric cancer (in combination with paclitaxel)",
            "offlabel_use_uri": "http://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Olaparib_LYNPARZA_Drug_Monograph.pdf",
            "offlabel_use_comment": " ",
            "clinical_trial": "NCT02208375",
            "condition_treatment_modality": "Primary",
            "condition_do_imprecise": false,
            "condition_mesh_imprecise": false,
            "mesh_id": 10040.0,
            "do_id": 4412.0,
            "is_fda_use": true,
            "fda_use_uri": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
            "fda_use_comment": "The indication is approved under accelerated approval based on objective response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.",
            "is_product_manual": false,
            "highest_phase_discontinued": false,
            "product_discontinued": false,
            "is_product_date_unknown": false,
            "target_refs": [
                1442,
                1443,
                1444
            ],
            "condition_id": 1137
        }
    ],
    "targets": [
        {
            "primary_target_id": "Q9Y6F1",
            "compound_id": 8.0,
            "target_primary_target_type": "UniProt",
            "primary_target_uri": "http://www.ncbi.nlm.nih.gov/pubmed/27487106",
            "target_primary_potency_type": "Unknown",
            "primary_potency_uri": "Unknown",
            "target_pharmacology": "Inhibitor",
            "primary_target_label": "Poly [ADP-ribose] polymerase 3",
            "primary_target_gene_symbol": "PARP3",
            "primary_target_gene_id": "10039",
            "primary_target_organism": "Homo sapiens (Human)",
            "condition_refs": [
                1137
            ],
            "target_id": 1444
        },
        {
            "primary_target_id": "P09874",
            "compound_id": 8.0,
            "target_primary_target_type": "UniProt",
            "primary_target_uri": "http://www.ncbi.nlm.nih.gov/pubmed/27487106",
            "target_primary_potency_type": "IC50",
            "target_primary_potency_value": "1.93999999999999995",
            "target_primary_potency_dimensions": "nM",
            "primary_potency_uri": "http://www.ncbi.nlm.nih.gov/pubmed/23881923",
            "target_pharmacology": "Inhibitor",
            "primary_target_label": "Poly [ADP-ribose] polymerase 1",
            "primary_target_gene_symbol": "PARP1",
            "primary_target_gene_id": "142",
            "primary_target_organism": "Homo sapiens (Human)",
            "condition_refs": [
                1137
            ],
            "target_id": 1442
        },
        {
            "primary_target_id": "Q9UGN5",
            "compound_id": 8.0,
            "target_primary_target_type": "UniProt",
            "primary_target_uri": "http://www.ncbi.nlm.nih.gov/pubmed/27487106",
            "target_primary_potency_type": "Unknown",
            "primary_potency_uri": "Unknown",
            "target_pharmacology": "Inhibitor",
            "primary_target_label": "Poly [ADP-ribose] polymerase 2",
            "primary_target_gene_symbol": "PARP2",
            "primary_target_gene_id": "10038",
            "primary_target_organism": "Homo sapiens (Human)",
            "condition_refs": [
                1137
            ],
            "target_id": 1443
        }
    ],
    "pk": [
        {
            "pk_age_group": "ADULT",
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "BLOOD",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_hours": "12",
            "pk_auc_type": "t",
            "pk_auc_units": "\u03bcg \u00d7 h/mL",
            "pk_auc_value": "31.7",
            "pk_cmax_units": "\u03bcg/mL",
            "pk_cmax_value": "6.88",
            "pk_dose_type": "UNKNOWN",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "SINGLE",
            "pk_food_status": "UNKNOWN",
            "pk_health_status": "UNHEALTHY",
            "pk_routes": "Oral",
            "pk_sex": "FEMALE / MALE",
            "pk_source_type": "EXPERIMENT",
            "pk_source_uri": "https://www.ncbi.nlm.nih.gov/pubmed/30887180",
            "pk_species": "Homo sapiens",
            "pk_thalf_units": "h",
            "pk_thalf_value": "6.52"
        },
        {
            "pk_age_group": "ADULT",
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "BLOOD",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_hours": "12",
            "pk_auc_type": "t",
            "pk_auc_units": "\u03bcg \u00d7 h/mL",
            "pk_auc_value": "10.9",
            "pk_cmax_units": "\u03bcg/mL",
            "pk_cmax_value": "2.97",
            "pk_dose_type": "UNKNOWN",
            "pk_dose_units": "mg",
            "pk_dose_value": "100",
            "pk_experiment_type": "MULTIPLE",
            "pk_food_status": "UNKNOWN",
            "pk_frequency_period": "day",
            "pk_frequency_times": "2",
            "pk_health_status": "UNHEALTHY",
            "pk_routes": "Oral",
            "pk_sex": "FEMALE / MALE",
            "pk_source_type": "EXPERIMENT",
            "pk_source_uri": "https://www.ncbi.nlm.nih.gov/pubmed/30887180",
            "pk_species": "Homo sapiens",
            "pk_thalf_units": "h",
            "pk_thalf_value": "7.17"
        },
        {
            "pk_age_group": "ADULT",
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "BLOOD",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_type": "\u221e",
            "pk_auc_units": "\u03bcg \u00d7 h/mL",
            "pk_auc_value": "44",
            "pk_cmax_units": "\u03bcg/mL",
            "pk_cmax_value": "8.27",
            "pk_dose_type": "UNKNOWN",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "STEADY-STATE",
            "pk_food_status": "UNKNOWN",
            "pk_frequency_period": "day",
            "pk_frequency_times": "2",
            "pk_health_status": "UNHEALTHY",
            "pk_routes": "Oral",
            "pk_sex": "FEMALE / MALE",
            "pk_source_type": "EXPERIMENT",
            "pk_source_uri": "https://www.ncbi.nlm.nih.gov/pubmed/30887180",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_age_group": "ADULT",
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "BLOOD",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_type": "\u221e",
            "pk_auc_units": "\u03bcg \u00d7 h/mL",
            "pk_auc_value": "16.7",
            "pk_cmax_units": "\u03bcg/mL",
            "pk_cmax_value": "3.75",
            "pk_dose_type": "UNKNOWN",
            "pk_dose_units": "mg",
            "pk_dose_value": "100",
            "pk_experiment_type": "STEADY-STATE",
            "pk_food_status": "UNKNOWN",
            "pk_frequency_period": "day",
            "pk_frequency_times": "2",
            "pk_health_status": "UNHEALTHY",
            "pk_routes": "Oral",
            "pk_sex": "FEMALE / MALE",
            "pk_source_type": "EXPERIMENT",
            "pk_source_uri": "https://www.ncbi.nlm.nih.gov/pubmed/30887180",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_age_group": "UNKNOWN",
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "PLASMA",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_food_status": "UNKNOWN",
            "pk_funbound_comment": "The in vitro protein binding of olaparib is approximately 82%",
            "pk_funbound_value": "18",
            "pk_health_status": "UNKNOWN",
            "pk_sex": "UNKNOWN",
            "pk_source_type": "DRUG LABEL",
            "pk_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208558s001lbl.pdf",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "plasma",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_hours": "12",
            "pk_auc_type": "t",
            "pk_auc_units": "ug*h/mL",
            "pk_auc_value": "43.9499999999999",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "single",
            "pk_frequency_period": "day",
            "pk_frequency_times": "2",
            "pk_health_status": "unhealthy",
            "pk_routes": "oral",
            "pk_source_type": "Clinical Trial",
            "pk_source_uri": "https://clinicaltrials.gov/ct2/show/NCT02430311",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "plasma",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_hours": "12",
            "pk_auc_type": "t",
            "pk_auc_units": "ug*h/mL",
            "pk_auc_value": "43.91",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "single",
            "pk_frequency_period": "day",
            "pk_frequency_times": "2",
            "pk_health_status": "unhealthy",
            "pk_routes": "oral",
            "pk_source_type": "Clinical Trial",
            "pk_source_uri": "https://clinicaltrials.gov/ct2/show/NCT02430311",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "plasma",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_cmax_units": "ug/mL",
            "pk_cmax_value": "6.875",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "single",
            "pk_health_status": "unhealthy",
            "pk_routes": "oral",
            "pk_source_type": "Clinical Trial",
            "pk_source_uri": "https://clinicaltrials.gov/ct2/show/NCT02430311",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "plasma",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_hours": "12",
            "pk_auc_type": "t",
            "pk_auc_units": "ug*h/mL",
            "pk_auc_value": "31.68",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "single",
            "pk_health_status": "unhealthy",
            "pk_routes": "oral",
            "pk_source_type": "Clinical Trial",
            "pk_source_uri": "https://clinicaltrials.gov/ct2/show/NCT02430311",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "plasma",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_hours": "48",
            "pk_auc_type": "t",
            "pk_auc_units": "ug*h/mL",
            "pk_auc_value": "36.37",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "single",
            "pk_health_status": "unhealthy",
            "pk_routes": "oral",
            "pk_source_type": "Clinical Trial",
            "pk_source_uri": "https://clinicaltrials.gov/ct2/show/NCT02430311",
            "pk_species": "Homo sapiens"
        },
        {
            "pk_analyte_cid": "23725625",
            "pk_analyte_mw": "434.4628",
            "pk_analyte_pt": "OLAPARIB",
            "pk_analyte_query": "OLAPARIB",
            "pk_analyte_smiles": "FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5",
            "pk_analyte_tissue": "plasma",
            "pk_analyte_unii": "WOH1JD9AR8",
            "pk_auc_type": "?",
            "pk_auc_units": "ug*h/mL",
            "pk_auc_value": "36.53",
            "pk_dose_units": "mg",
            "pk_dose_value": "300",
            "pk_experiment_type": "single",
            "pk_health_status": "unhealthy",
            "pk_routes": "oral",
            "pk_source_type": "Clinical Trial",
            "pk_source_uri": "https://clinicaltrials.gov/ct2/show/NCT02430311",
            "pk_species": "Homo sapiens"
        }
    ],
    "ddi": [
        {
            "ddi_clin_comment": "Itraconazole (strong CYP3A inhibitor) increased the AUC of olaparib by 2.7-fold and PBPK modeling predicted that fluconazole (moderate CYP3A inhibitor) would likely increase olaparib AUC by 2-fold.",
            "ddi_clin_evidence": "co-administration study",
            "ddi_clin_support": "yes",
            "ddi_relation": "substrate",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "CYP3A",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=4",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "substrate",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "CYP2A6",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=29",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "substrate",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "CYP1A1",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=29",
            "ddi_page": "-"
        },
        {
            "ddi_comment": "Up to 1.5 fold induction of CYP2B6 was observed with 3 \u00b5M of olaparib and up to 3.2 fold induction at the olaparib concentration of 30 \u00b5M. T",
            "ddi_relation": "inducer",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "CYP2B6",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "substrate",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "P-gp",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=34",
            "ddi_page": "-"
        },
        {
            "ddi_comment": "Data suggests that olaparib is a substrate of organic anion transporters (OATs) but the sponsor was not able to specify which ones due to large variability in the study KMX042.",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "OAT",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "37.9",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "OCT1",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "19.9",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "OCT2",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "18.4",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "OAT3",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "5.5",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "MATE1",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "47.1",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "MATE2",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "20.3",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "OATP1B1",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_comment": "Olaparib 10 \u00b5M inhibited the efflux of calcein (MRP2 substrate) by 25% in MDCKII cells transfected with MRP2.",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "MRP2",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=35",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inducer",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "CYP3A4",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=79",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inducer",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP1A2",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inducer",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2C9",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inducer",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2C19",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inducer",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP3A",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP1A2",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2A6",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2B6",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2C8",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2C9",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2C19",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2D6",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "10",
            "ddi_concentration": ">100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "CYP2E1",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_activity": "44",
            "ddi_concentration": "100",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "CYP3A",
            "ddi_type": "Inhibition",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=33",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "substrate",
            "ddi_reported_magnitude": "no",
            "ddi_target": "BCRP",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=34",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "BCRP",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=34",
            "ddi_page": "-"
        },
        {
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "no",
            "ddi_target": "P-gp",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf#page=34",
            "ddi_page": "-"
        },
        {
            "ddi_concentration": "226",
            "ddi_relation": "inhibitor",
            "ddi_reported_magnitude": "yes",
            "ddi_target": "hERG",
            "ddi_type": "IC50",
            "ddi_url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000PharmR.pdf#page=58",
            "ddi_page": "-"
        }
    ],
    "toxicity": [
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "300",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208558s000lbl.pdf |https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208558Orig1s000MultidisciplineR.pdf",
            "toxicity_species": "Homo sapiens",
            "aes": [
                {
                    "adverseevents_frequency": "24",
                    "adverseevents_liability": "Anemia",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption or reduction |leads to discontinuation"
                },
                {
                    "adverseevents_frequency": "20",
                    "adverseevents_liability": "Anemia",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption or reduction |leads to discontinuation"
                },
                {
                    "adverseevents_frequency": "9",
                    "adverseevents_liability": "Neutropenia",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption or reduction |leads to discontinuation"
                },
                {
                    "adverseevents_frequency": "73",
                    "adverseevents_liability": "Nausea",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption"
                },
                {
                    "adverseevents_frequency": "3",
                    "adverseevents_liability": "Nausea",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption"
                },
                {
                    "adverseevents_frequency": "34",
                    "adverseevents_liability": "Vomiting",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption"
                },
                {
                    "adverseevents_frequency": "3",
                    "adverseevents_liability": "Vomiting",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption"
                }
            ],
            "tox_id": 34
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "300",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208558s000lbl.pdf",
            "toxicity_species": "Homo sapiens",
            "aes": [
                {
                    "adverseevents_frequency": "62",
                    "adverseevents_liability": "Fatigue",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption or reduction"
                },
                {
                    "adverseevents_frequency": "4",
                    "adverseevents_liability": "Fatigue",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption or reduction"
                },
                {
                    "adverseevents_frequency": "31",
                    "adverseevents_liability": "Diarrhea",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "2",
                    "adverseevents_liability": "Diarrhea",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Abscess oral",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Aphthous ulcer",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Gingival abscess",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Gingival disorder",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Gingival pain",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Gingivitis",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Mouth ulceration",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Mucosal infection",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Mucosal inflammation",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oral candidiasis",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oral discomfort",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oral herpes",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oral infection",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oral mucosal erythema",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oral pain",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oropharyngeal discomfort",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "19",
                    "adverseevents_liability": "Oropharyngeal pain",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Abscess oral",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Aphthous ulcer",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Gingival abscess",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Gingival disorder",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Gingival pain",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Gingivitis",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Mouth ulceration",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Mucosal infection",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Mucosal inflammation",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oral candidiasis",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oral discomfort",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oral herpes",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oral infection",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oral mucosal erythema",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oral pain",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oropharyngeal discomfort",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Oropharyngeal pain",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "36",
                    "adverseevents_liability": "Nasopharyngitis",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "36",
                    "adverseevents_liability": "Sinusitis",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "36",
                    "adverseevents_liability": "Rhinitis",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "36",
                    "adverseevents_liability": "Influenza",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "22",
                    "adverseevents_liability": "Decreased appetite",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "30",
                    "adverseevents_liability": "Arthralgia",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "30",
                    "adverseevents_liability": "Myalgia",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "27",
                    "adverseevents_liability": "Dysgeusia",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "25",
                    "adverseevents_liability": "Headache",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Headache",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Rash"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Cough"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Dyspepsia"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Leukopenia"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Hypomagnesemia"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Dizziness"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Thrombocytopenia"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Creatinine increased"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Lymphopenia"
                },
                {
                    "adverseevents_frequency": "<20",
                    "adverseevents_liability": "Edema"
                },
                {
                    "adverseevents_frequency": "89",
                    "adverseevents_liability": "Mean corpuscular volume increased",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "66",
                    "adverseevents_liability": "Decreased hemoglobin",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "17",
                    "adverseevents_liability": "Decreased hemoglobin",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "64",
                    "adverseevents_liability": "Leukocyte count decreased",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "5",
                    "adverseevents_liability": "Leukocyte count decreased",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "56",
                    "adverseevents_liability": "Lymphocyte count low",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "11",
                    "adverseevents_liability": "Lymphocyte count low",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "44",
                    "adverseevents_liability": "Absolute neutrophil count decreased",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "7",
                    "adverseevents_liability": "Absolute neutrophil count decreased",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "44",
                    "adverseevents_liability": "Creatinine serum increased",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "40",
                    "adverseevents_liability": "Platelets decreased",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "2",
                    "adverseevents_liability": "Platelets decreased",
                    "adverseevents_severity": "grade 3-4"
                }
            ],
            "tox_id": 33
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "300",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208558Orig1s000MultidisciplineR.pdf",
            "toxicity_species": "Homo sapiens",
            "aes": [
                {
                    "adverseevents_frequency": "9 pts",
                    "adverseevents_liability": "Thrombocytopenia",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to discontinuation | leads to dose interruption"
                },
                {
                    "adverseevents_frequency": "2 pts",
                    "adverseevents_liability": "Myelodysplastic syndrome",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to discontinuation"
                },
                {
                    "adverseevents_frequency": "2 pts",
                    "adverseevents_liability": "Acute myeloid leukemia",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to discontinuation"
                }
            ],
            "tox_id": 35
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended|MTD",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "400",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
            "toxicity_species": "Homo sapiens",
            "toxicity_dose_comment": "400 mg BID was the MTD for the capsule formulation",
            "aes": [
                {
                    "adverseevents_frequency": "<1",
                    "adverseevents_liability": "Myelodysplastic syndrome",
                    "adverseevents_severity": "grade 5",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "WARNING"
                },
                {
                    "adverseevents_frequency": "<1",
                    "adverseevents_liability": "Acute myeloid leukemia",
                    "adverseevents_severity": "grade 5",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "WARNING"
                }
            ],
            "tox_id": 37
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended|MTD",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "400",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
            "toxicity_species": "Homo sapiens",
            "toxicity_dose_comment": "400 mg BID was the MTD for the capsule formulation",
            "aes": [
                {
                    "adverseevents_frequency": "<1",
                    "adverseevents_liability": "Pneumonitis",
                    "adverseevents_severity": "grade 5",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "WARNING"
                }
            ],
            "tox_id": 38
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended|MTD",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "400",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf",
            "toxicity_species": "Homo sapiens",
            "toxicity_dose_comment": "400 mg BID was the MTD for the capsule formulation",
            "aes": [
                {
                    "adverseevents_frequency": "16",
                    "adverseevents_liability": "Anemia",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "18",
                    "adverseevents_liability": "Anemia",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "35",
                    "adverseevents_liability": "Abdominal discomfort",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "8",
                    "adverseevents_liability": "Abdominal discomfort",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "21",
                    "adverseevents_liability": "Decreased appetite",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Decreased appetite",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "30",
                    "adverseevents_liability": "Diarrhea",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "1",
                    "adverseevents_liability": "Diarrhea",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "25",
                    "adverseevents_liability": "Dyspepsia",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "58",
                    "adverseevents_liability": "Asthenia",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "8",
                    "adverseevents_liability": "Asthenia",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "26",
                    "adverseevents_liability": "Nasopharyngitis",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "21",
                    "adverseevents_liability": "Arthralgia",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "21",
                    "adverseevents_liability": "Musculoskeletal pain",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "22",
                    "adverseevents_liability": "Myalgia",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "18",
                    "adverseevents_liability": "Neutropenia",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "7",
                    "adverseevents_liability": "Neutropenia",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "39",
                    "adverseevents_liability": "Lymphopenia",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "17",
                    "adverseevents_liability": "Lymphopenia",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "57",
                    "adverseevents_liability": "Mean corpuscular volume increased",
                    "adverseevents_severity": "grade 1-4"
                },
                {
                    "adverseevents_frequency": "28",
                    "adverseevents_liability": "Creatinine increased",
                    "adverseevents_severity": "grade 1-2"
                },
                {
                    "adverseevents_frequency": "2",
                    "adverseevents_liability": "Creatinine increased",
                    "adverseevents_severity": "grade 3-4"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Cough"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Constipation"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Dysgeusia"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Peripheral edema"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Back pain"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Dizziness"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Headache"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Urinary tract infection"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Dyspnea"
                },
                {
                    "adverseevents_frequency": "10-20",
                    "adverseevents_liability": "Rash"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Leukopenia"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Stomatitis"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Peripheral neuropathy"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Pyrexia"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Hypomagnesemia"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Hyperglycemia"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Anxiety"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Depression"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Insomnia"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Dysuria"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Urinary incontinence"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Vulvovaginal disorder"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Dry skin"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Eczema"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Pruritis"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Hypertension"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Venous thrombosis"
                },
                {
                    "adverseevents_frequency": "1-10",
                    "adverseevents_liability": "Hot flush"
                }
            ],
            "tox_id": 36
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Recommended|MTD",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "400",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf |https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208558Orig1s000MultidisciplineR.pdf",
            "toxicity_species": "Homo sapiens",
            "toxicity_dose_comment": "400 mg BID was the MTD for the capsule formulation",
            "aes": [
                {
                    "adverseevents_frequency": "3",
                    "adverseevents_liability": "Nausea",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "39",
                    "adverseevents_liability": "Vomiting",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "4",
                    "adverseevents_liability": "Vomiting",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "8",
                    "adverseevents_liability": "Fatigue",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "75",
                    "adverseevents_liability": "Anemia",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "15",
                    "adverseevents_liability": "Anemia",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "27",
                    "adverseevents_liability": "Thrombocytopenia",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption"
                },
                {
                    "adverseevents_frequency": "3",
                    "adverseevents_liability": "Thrombocytopenia",
                    "adverseevents_severity": "grade 3-4",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose interruption"
                },
                {
                    "adverseevents_frequency": "61",
                    "adverseevents_liability": "Nausea",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                },
                {
                    "adverseevents_frequency": "58",
                    "adverseevents_liability": "Fatigue",
                    "adverseevents_severity": "grade 1-2",
                    "adverseevents_type": "discontinuation",
                    "adverseevents_comment": "leads to dose reduction or interruption"
                }
            ],
            "tox_id": 39
        },
        {
            "compound_id": 8,
            "toxicity_dose_type": "Highest studied dose",
            "toxicity_dose_units": "mg",
            "toxicity_dose_value": "600",
            "toxicity_experiment_type": "steady",
            "toxicity_frequency_period": "day",
            "toxicity_frequency_times": "2",
            "toxicity_health_status": "unhealthy",
            "toxicity_routes": "oral",
            "toxicity_source_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206162Orig1s000ClinPharmR.pdf",
            "toxicity_species": "Homo sapiens",
            "aes": [
                {
                    "adverseevents_comment": "No information on AEs is available"
                }
            ],
            "tox_id": 32
        },
        {
            "compound_id": 8,
            "aes": [
                {
                    "adverseevents_type": "dose interruption"
                }
            ],
            "tox_id": 5508
        },
        {
            "compound_id": 8,
            "tox_id": 5509
        }
    ],
    "sourcing": [
        {
            "sourcing_vendor_name": "ChEBI",
            "sourcing_vendor_substance_url": "https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:83766",
            "sourcing_vendor_type": "database",
            "sourcing_vendor_substance_id": "CHEBI:83766"
        },
        {
            "sourcing_vendor_name": "ChemicalBook",
            "sourcing_vendor_substance_url": "https://www.chemicalbook.com/ChemicalProductProperty_EN_CB02473811",
            "sourcing_vendor_type": "vendor",
            "sourcing_vendor_substance_id": "CB02473811"
        },
        {
            "sourcing_vendor_name": "ChemicalBook",
            "sourcing_vendor_substance_url": "https://www.chemicalbook.com/ChemicalProductProperty_EN_CB02756176",
            "sourcing_vendor_type": "vendor",
            "sourcing_vendor_substance_id": "CB02756176"
        },
        {
            "sourcing_vendor_name": "eMolecules",
            "sourcing_vendor_substance_url": "https://www.emolecules.com/cgi-bin/more?vid=31526131",
            "sourcing_vendor_type": "vendor",
            "sourcing_vendor_substance_id": "31526131"
        },
        {
            "sourcing_vendor_name": "MolPort",
            "sourcing_vendor_substance_url": "https://www.molport.com/shop/molecule-link/MolPort-009-679-395",
            "sourcing_vendor_type": "vendor",
            "sourcing_vendor_substance_id": "MolPort-009-679-395"
        },
        {
            "sourcing_vendor_name": "Selleck Chemicals",
            "sourcing_vendor_substance_url": "http://www.selleckchem.com/products/AZD2281(Olaparib).html",
            "sourcing_vendor_type": "vendor",
            "sourcing_vendor_substance_id": "AZD2281(Olaparib)"
        },
        {
            "sourcing_vendor_name": "ZINC",
            "sourcing_vendor_substance_url": "http://zinc15.docking.org/substances/ZINC000040430143",
            "sourcing_vendor_type": "database",
            "sourcing_vendor_substance_id": "ZINC000040430143"
        }
    ]
}]